Rabbit Thrombin

Synonyms: 兔凝血酶
Rabbit Thrombin 是一种丝氨酸蛋白酶,可与 Antithrombin III (MS-Q96591) 形成共价复合物,可逆性结合内皮细胞表面的高亲和力位点,调控 VEGF 和 Ang-2,增强 VEGF 的促有丝分裂活性,保护内皮细胞免于凋亡 (apoptosis),并可用于后肢缺血相关研究。
产品编号: MS-R28513 CAS No.: 9002-04-4
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
100μg
询价
询价

产品描述

Rabbit Thrombin 是一种丝氨酸蛋白酶,可与 Antithrombin III (MS-Q96591) 形成共价复合物,可逆性结合内皮细胞表面的高亲和力位点,调控 VEGF 和 Ang-2,增强 VEGF 的促有丝分裂活性,保护内皮细胞免于凋亡 (apoptosis),并可用于后肢缺血相关研究。

生物实验数据

生物活性 Rabbit Thrombin is a serine protease that forms a covalent complex with Antithrombin III (MS-Q96591), reversibly binds to high-affinity sites on the endothelial cell surface, regulates VEGF and Ang-2, enhances the mitogenic activity of VEGF, protects endothelial cells from apoptosis, and can be used in research related to hindlimb ischemia.
体外研究
(In Vitro)

Rabbit Thrombin 在体外兔全血中与 Antithrombin III 形成复合物。

体内研究
(In Vivo)

Rabbit Thrombin 从兔体内循环中的清除速度慢于活性位点封闭的 Thrombin (MS-B49083),1 分钟时约 75% 仍留存于循环中。
Rabbit Thrombin (500-15000 IU;肌内注射;单次给药) 可在兔后肢缺血模型中促进剂量依赖性的动脉生成及血流动力学恢复。

Animal Model: New Zealand White (male, approximately 6-month-old, weight 3.0-4.0 kg, bilateral femoral artery surgical excision to induce hindlimb ischemia)
Dosage: 500 IU; 1500 IU; 5000 IU; 15,000 IU
Administration: intramuscular; single administration
Result: Induced a 30.2% increase in total collateral vessel area and length compared to control ischemic limbs.
Doubled the arteriolar count per optical field in adductor muscle compared to control limbs.
Increased saphenous artery peak enhancement by 100.9% compared to control limbs.
Reduced time-to-peak enhancement significantly.
Achieved a semiquantitative slope method perfusion score of 5.7, which was not significantly inferior to normal nonoperated limbs (score 6.5).
Evoked a pronounced arteriogenic response in both treated and contralateral control limbs, with total collateral vessel area of 10,879 pixels (treated) and 10,384 pixels (control), compared to 5882 pixels in ischemic internal control limbs.
Increased mean collateral diameter in both treated (2.77 pixels) and control (2.75 pixels) limbs compared to normal nonoperated subjects (2.66 pixels).
Increased saphenous artery peak enhancement by 70-80% compared to normal subjects, with significantly delayed time-to-peak intervals.
Achieved a semiquantitative perfusion score of 5.4, similar to normal limbs.
Increased arteriolar counts in both treated and contralateral control limbs, but caused abundant inflammatory cell infiltration in the treated limb.
Did not produce statistically significant increases in collateral vessel area or length compared to control limbs.

化学信息

CAS No. 9002-04-4
别名 兔凝血酶

储存&溶解度

溶解度信息
H2O: 50 mg/mL, Sonication is recommended.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础